BioNTech yesterday announced its intention to acquire CureVac. The transaction could also end the global patent disputes between the two biotech companies in Germany, the UK, and the US. In a press
Context: 10x Genomics was an “early adopter” of the United Patent Court (UPC) with its patent enforcement against NanoString. That dispute has meanwhile been settled on terms presumably favorable to
http://pss-system.cnipa.gov.cn/sipopublicsearch/portal/uilogin-forwardLogin.shtml?version=tem
https://www.epo.org/searching-for-patents.html
https://www.cnipa.gov.cn/col/col1518/index.html
US chipmaker Nvidia has sued rival Qualcomm and handset maker Samsung, saying the two have infringed on its patents on graphics processing technology. The lawsuit is asking a US court to prevent shipm...
have had many bad experiences with core technologies at the hands of others. For instance, in the 3G era, to avoid paying huge patent royalties to the companies that developed the globally recognized 3G
The Chinese government, judicial institutions and companies have introduced numerous innovative measures in recent years to protect intellectual property rights, in the face of ever-more sophisticated...
The UK government has prepared legislation to give effect to EU legislation on the unitary patent and to the Agreement on the Unified Patent Court (UPC), which backs the creation of a new UPC for
SAN FRANCISCO, Feb. 22 (Xinhua) -- Microsoft on Wednesday accused Motorola Mobility and Google of standard patent abuse in its latest antitrust complaint with the European Union. In the formal